February 15, 2025

Wellness Sync

Start the Day with a Smile, Finish with Health

High Potential of Gastrointestinal Agents Across Hospitals & Clinics As Part of Initial Treatment and Ongoing Management Plans for Patients

High Potential of Gastrointestinal Agents Across Hospitals & Clinics As Part of Initial Treatment and Ongoing Management Plans for Patients

Company Logo
Company Logo

Global Gastrointestinal Agents Market

Global Gastrointestinal Agents Market
Global Gastrointestinal Agents Market

Dublin, Aug. 12, 2024 (GLOBE NEWSWIRE) — The “Gastrointestinal Agents Market by Type (Dietary Supplements, Drugs), Disease Type (Constipation, Diarrhea, Gastroesophageal Reflux Disease), Route of Administration, Distribution Channel, End-User – Forecast 2024-2030” report has been added to ResearchAndMarkets.com’s offering.

The Gastrointestinal Agents Market grew from USD 57.26 billion in 2023 to USD 60.06 billion in 2024. It is expected to continue growing at a CAGR of 4.97%, reaching USD 80.47 billion by 2030.

The rise in gastrointestinal diseases around the world, including conditions such as gastroesophageal reflux disease, peptic ulcers, and inflammatory bowel disease (IBD), drives the need for effective gastrointestinal agents. Growing awareness about gastrointestinal health and improved access to healthcare services in developing regions also contribute to the expanded use of GI agents.

High treatment costs and drug resistance issues with gastrointestinal agents hamper the market growth. Ongoing research and development in gastroenterology led to introduction of more effective and safer drugs, which are expected to create opportunities for gastrointestinal agent market.

Regional Insights

In the Americas, the gastrointestinal agents market is highly developing due to advanced healthcare systems, high awareness of gastrointestinal disorders, and substantial investments in healthcare. The higher prevalence of gastrointestinal diseases and the strong presence of pharmaceutical companies create a platform for the gastrointestinal agents market. In South America, improvements in healthcare infrastructure and increased health insurance coverage are gradually boosting the market.

The APAC region is seeing rapid growth in the gastrointestinal agents market driven by increasing population, rising healthcare expenditures, and growing awareness of gastrointestinal disorders. Countries such as Japan, China, and India are leading this growth due to their large populations and increasing middle class, which has better access to healthcare services. Additionally, Asia-Pacific is experiencing a shift towards Western diets, increasing the prevalence of gastrointestinal issues.

Europe is a major region in the global gastrointestinal agents market, with advanced healthcare systems and a high prevalence of gastrointestinal diseases. Regulatory support and the presence of major pharmaceutical companies also contribute to the growth of this market.

The Gulf Cooperation Council (GCC) countries show higher market penetration due to better healthcare infrastructure, while other parts of Africa are emergent markets with limited access to healthcare.

Market Insights

link